Revenues at AstraZeneca have jumped 48% in the first six months of 2022 (Yui Mok/PA)
(Picture: PA Wire)British pharma giant AstraZeneca said its Farxiga drug significantly lowers death in patients who have already suffered heart failure in a major breakthrough for people with heart disease.
The announcement follows a trial of the drug in over 11,000 patients with heart conditions which found its use leads to a 14% drop in the risk of death and a 29% drop in the rate of hospitalisations compared with using a placebo.
